Health
Inflammasome Therapeutics Says Study of Approximately 130000 People Reported in Nature Communications Points to Potential for Treatment or Prevention of Diabetes and Other Inflammasome-Mediated Diseases with Company’s Drugs – Business Wire
Inflammasome Therapeutics says study in Nature Communications points to potential treatment or prevention of diabetes with company’s drugs
NEWTON, Mass.–(BUSINESS WIRE)–Inflammasome Therapeutics (http://www.inflam.com), a privately held company developing therapies for prevalent, degenerative diseases, reported that data analyses published today in Nature Communications https://www.nature.com/articles/s41467-020-18528-z showed that patients taking nucleoside reverse transcriptase inhibitors (NRTIs), drugs used to treat HIV for more than 30 years, reduced their risk of developing type 2 diabetes by 33%, a highly statistically sign…
-
Business24 hours agoWhy Amotiv, Breville, Life360, and Woodside shares are tumbling today
-
Noosa News22 hours agoDevastating update in search for missing Queensland mother Tayla Spies as police find human remains near her ute
-
Noosa News23 hours agoNicole Kidman Is Back in Wellness Guru Mode: ‘Nine Perfect Strangers’ Season Two Will Hit Your Streaming Queue in May
-
Noosa News20 hours agoCloud Control celebrate 15 years of debut album Bliss Release with reunion tour